Palliative care in end-stage kidney disease.

摘要: Patients with end-stage kidney disease have significantly increased morbidity and mortality. While greater attention has been focused on advanced care planning, end-of-life decisions, conservative therapy withdrawal from dialysis these must be supported by adequate palliative incorporating symptom control. With the increase in elderly, their inherent comorbidities, accepted onto dialysis, patients, nephrologists, families multidisciplinary teams, are often faced decisions provision of care. may offer a better quality quantity life compared management, this not always case; hence patient is entitled to well-informed all options potential outcomes before embarking such therapy. They should assured control whichever option selected. No randomized controlled trials conducted area only small number observational studies provide guidance; thus predicting which patients will poor problematic. Those undertaking benefit being fully aware choices between active treatment functional status seriously deteriorate shared caregivers. This clarifies pathways reduces ambiguity surrounding decision making. If or chosen, each The objective review summarize published evidence-based guidelines, core curricula, position statements, standards tools disease.